Skip to main content

Table 3 The correlation between clinical course of myositis and cancer

From: Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study

Autoantibodies

Patients with paralleled clinical course, numbera

Patients with non-paralleled clinical course, number

Total numberb

Anti-TIF1-γ

20

14

34

Anti-NXP2

2

1

3

Anti-SAE1

2

2

4

Anti-HMGCR

1

0

1

Anti-SRP

0

1

1

Anti-Jo-1

1

4

5

Anti-PL-7

0

1

1

Anti-PL-12

1

2

3

Anti-EJ

0

1

1

Anti-MDA5

0

1

1

MSAs-c

3

10

13

  1. Abbreviations: MSAs myositis specific autoantibodies
  2. aA paralleled clinical course meant that myositis emerged/deteriorated with the progression/recurrence of previously diagnosed cancers, cancer emerged with the recurrence of previously diagnosed IIMs, and/or myositis improved after removal or effective treatment of the cancer
  3. bFour patients with anti-TIF1-γ and one MSA-negative patient were lost to follow up
  4. cNegative for all of the listed MSAs
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us